These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22416398)

  • 1. [Support of hematological homeostasis during chemotherapy with taxanes].
    Koroleva IA; Mochalova AS
    Vopr Onkol; 2011; 57(6):784-8. PubMed ID: 22416398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Administration of dicarbamin in the course of taxotere-assisted chemotherapy].
    Koroleva IA; Mochalova AS
    Vopr Onkol; 2011; 57(2):250, 252-4. PubMed ID: 21809675
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of neutropenia during adjuvant taxotere therapy for breast cancer].
    Mochalova AS; Koroleva IA
    Vopr Onkol; 2012; 58(6):813-6. PubMed ID: 23600309
    [No Abstract]   [Full Text] [Related]  

  • 4. [Potential hemoprotective effect of dicarbamin in chemoradiotherapy for malignant tumors].
    Dzhabarov FR; Rozenko LIa; Gus'kova NK
    Vopr Onkol; 2012; 58(4):572-7. PubMed ID: 23607219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Febrile neutropenia incidence and hematological toxicity with the FEC100-docetaxel regimen in the treatment of early-stage breast cancer.
    Cousin S; Le Rhun E; Mailliez A; Fournier C; Bonneterre J
    Bull Cancer; 2012; 99(7-8):75-80. PubMed ID: 22713627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma.
    Abaid LN; Micha JP; Rettenmaier MA; Brown JV; Mendivil AA; Lopez KL; Goldstein BH
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):101-7. PubMed ID: 23660691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy with TAC (docetaxel, doxorubicin, and cyclophosphamide) in patients with breast cancer--incidence of neutropenic fever outside clinical trials.
    Passos-Coelho JL; Esteves S; Vieira PA; Isidoro M; Ribeiro M; Oliveira J; Moreira AR
    Breast J; 2011; 17(5):539-41. PubMed ID: 21899649
    [No Abstract]   [Full Text] [Related]  

  • 8. New recommendation of doses in an ongoing phase II study of docetaxel, oxaliplatin and capecitabine as first line therapy in advanced gastro-oesophageal cancer.
    Schønnemann KR; Yilmaz M; Andersen M; Pfeiffer P
    Acta Oncol; 2011 Jan; 50(1):151-2. PubMed ID: 20843172
    [No Abstract]   [Full Text] [Related]  

  • 9. [Growth dynamics of transplantable murine tumors in the course of dicarbamin-protected chemotherapy].
    Sedakova LA; Treshchalina EM; Sitdikova SM; Nebol'sin VE
    Vopr Onkol; 2010; 56(5):591-2, 594-6. PubMed ID: 21137241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of pigmentary side effects of taxanes and anthracyclines: an onychoscopic evaluation.
    Yorulmaz A; Dogan M; Artuz F; Zengin N
    Cutan Ocul Toxicol; 2017 Jun; 36(2):135-139. PubMed ID: 27086693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and economic analysis of the feasibility of using Dicarbamine for the prevention of the toxic effects of antineoplastic chemotherapy].
    Mochalova AS; Koroleva IA
    Vopr Onkol; 2013; 59(5):637-41. PubMed ID: 24260894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of febrile neutropenia in breast cancer patients receiving epirubicin and docetaxel/paclitaxel with colony-stimulating growth factors: a comparison of filgrastim or lenograstim with pegfilgrastim.
    Schippinger W; Holub R; Dandachi N; Bauernhofer T; Samonigg H
    Oncology; 2006; 70(4):290-3. PubMed ID: 16899982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dicarbamine as a hemoprotective agent in patients with hemoblastoses treated with chemotherapy].
    Ivanova OV
    Vopr Onkol; 2012; 58(3):416-9. PubMed ID: 22888661
    [No Abstract]   [Full Text] [Related]  

  • 14. Experience with the management of neutropenia in gynecologic cancer patients receiving carboplatin-based chemotherapy.
    Markman J; Zanotti K; Webster K; Belinson J; Peterson G; Kulp B; Markman M
    Gynecol Oncol; 2004 Feb; 92(2):592-5. PubMed ID: 14766252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weekly docetaxel/paclitaxel in pretreated metastatic breast cancer.
    Gennari A; Guarneri V; Landucci E; Orlandini C; Rondini M; Salvadori B; Ricci S; Conte PF
    Clin Breast Cancer; 2002 Dec; 3(5):346-52. PubMed ID: 12533265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
    Yang S; Shi YK; Liu P; Han XH; He XH; Cai YM; Chen ZM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial.
    Takashima T; Mukai H; Hara F; Matsubara N; Saito T; Takano T; Park Y; Toyama T; Hozumi Y; Tsurutani J; Imoto S; Watanabe T; Sagara Y; Nishimura R; Shimozuma K; Ohashi Y;
    Lancet Oncol; 2016 Jan; 17(1):90-8. PubMed ID: 26617202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docetaxel, 5-fluorouracil, and leucovorin as treatment for advanced gastric cancer: results of a phase II study.
    Constenla M; Garcia-Arroyo R; Lorenzo I; Carrete N; Campos B; Palacios P
    Gastric Cancer; 2002; 5(3):142-7. PubMed ID: 12378340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity profile of taxanes in Tunisian cancer patients: A retrospective study of 90 cases.
    Ben Nasr S; Zribi A; Ben Hassen M; Doghri Y; Ben Abdallah I; Trigui E; Fendri S; Ayari J; Balti M; Haddaoui A
    Bull Cancer; 2021 Mar; 108(3):266-271. PubMed ID: 33423777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is chemotherapy-induced neutropenia a prognostic factor in patients with ovarian cancer?
    Kim JJ; Park JY; Kim DY; Kim JH; Kim YM; Nam JH; Kim YT
    Acta Obstet Gynecol Scand; 2010 May; 89(5):623-8. PubMed ID: 20423275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.